Ki Summary BindingDB logo
myBDB logout
Reaction Details
Report a problem with these data
TargetcGMP-inhibited 3',5'-cyclic phosphodiesterase 3B [650-1084]
LigandBDBM14772
Substrate/CompetitorBDBM10851
Meas. Tech.Phosphodiesterase (PDE) Inhibition Assay
IC50>200000±n/a nM
Citation Card, GLEngland, BPSuzuki, YFong, DPowell, BLee, BLuu, CTabrizizad, MGillette, SIbrahim, PNArtis, DRBollag, GMilburn, MVKim, SHSchlessinger, JZhang, KY Structural basis for the activity of drugs that inhibit phosphodiesterases. Structure12:2233-47 (2004) [PubMed]  Article
More Info.:Get all data from this article,   Solution Info,  Assay Method
 
cGMP-inhibited 3',5'-cyclic phosphodiesterase 3B [650-1084]
Name:cGMP-inhibited 3',5'-cyclic phosphodiesterase 3B [650-1084]
Synonyms:CGI-PDE B | CGIP1 | CGIPDE1 | Cyclic GMP-inhibited phosphodiesterase B | PDE3B | PDE3B_HUMAN | cGMP-inhibited 3',5'-cyclic phosphodiesterase B (aa 650-1084) | cGMP-inhibited 3',5'-cyclic phosphodiesterase B [650-1084] | cGMP-inhibited 3,5-cyclic phosphodiesterase B
Type:Enzyme
Mol. Mass.:49825.61
Organism:Homo sapiens (Human)
Description:Recombinant catalytic domain (Q650-A1084) of human PDE3B.
Residue:435
Sequence:
QTNIEQEVSLDLILVEEYDSLIEKMSNWNFPIFELVEKMGEKSGRILSQVMYTLFQDTGL
LEIFKIPTQQFMNYFRALENGYRDIPYHNRIHATDVLHAVWYLTTRPVPGLQQIHNGCGT
GNETDSDGRINHGRIAYISSKSCSNPDESYGCLSSNIPALELMALYVAAAMHDYDHPGRT
NAFLVATNAPQAVLYNDRSVLENHHAASAWNLYLSRPEYNFLLHLDHVEFKRFRFLVIEA
ILATDLKKHFDFLAEFNAKANDVNSNGIEWSNENDRLLVCQVCIKLADINGPAKVRDLHL
KWTEGIVNEFYEQGDEEANLGLPISPFMDRSSPQLAKLQESFITHIVGPLCNSYDAAGLL
PGQWLEAEEDNDTESGDDEDGEELDTEDEEMENNLNPKPPRRKSRRRIFCQLMHHLTENH
KIWKEIVEEEEKCKA
Blast this sequence in BindingDB or PDB
  Blast E-value cutoff:
BDBM14772
BDBM10851
NameBDBM14772
Synonyms:(R,S)-Mesopram | 5-(4-methoxy-3-propoxy-phenyl)-5-methyl-1,3-oxazolidin-2-one | 5-(4-methoxy-3-propoxyphenyl)-5-methyl-1,3-oxazolidin-2-one | Daxalipram
TypeSmall organic molecule
Emp. Form.C14H19NO4
Mol. Mass.265.305
SMILESCCCOc1cc(ccc1OC)C1(C)CNC(=O)O1
Structure
Search PDB for entries with ligand similarity:Similarity to this molecule at least: